Apixaban (Eliquis)

CAS NO: 503612-47-3

Batch Molecular Formula	C25H25N5O4
Batch Molecular Weight	459.497 g/mol
Physical Appearance	White to off white Solid
Solubility	40-50 μg/ml in 0.9% saline solution
Storage	Store at RT
Batch Molecular Structure

Apixaban, commonly known by the brand name Eliquis, is a medication classified as an oral anticoagulant or blood thinner. It is primarily used to prevent and treat conditions related to blood clots. Here are the main uses of Apixaban (Eliquis):

Atrial Fibrillation (AFib): Eliquis is commonly prescribed for individuals with atrial fibrillation, a heart rhythm disorder, to reduce the risk of stroke and systemic embolism. Atrial fibrillation can lead to the formation of blood clots in the heart, which can travel to the brain and cause a stroke. Eliquis helps prevent the formation of these clots.
Deep Vein Thrombosis (DVT): Apixaban is used to treat deep vein thrombosis, a condition where blood clots form in the deep veins, usually in the legs. It is also used to prevent the recurrence of DVT.
Pulmonary Embolism (PE): Eliquis is used in the treatment and prevention of pulmonary embolism, which occurs when a blood clot travels to the lungs and blocks a pulmonary artery.
Venous Thromboembolism (VTE) Prophylaxis: In some cases, Eliquis may be prescribed to prevent venous thromboembolism in individuals undergoing hip or knee replacement surgery.
Secondary Prevention of Cardiovascular Events: It can also be used for the secondary prevention of cardiovascular events in individuals with a history of certain types of heart attacks or unstable angina.

Eliquis is known for its convenience as it is taken orally, and it doesn’t require frequent monitoring of blood levels, unlike some other anticoagulants. However, it should be used under the supervision and guidance of a healthcare provider, as it can have potential side effects, and its use may need to be adjusted based on individual factors. Dosing and treatment duration are determined by the specific condition being treated and the patient’s health status. Regular check-ups are typically recommended for those taking Eliquis.

MEDICAL USE:

Eliquis is also used after hip or knee replacement surgery to prevent a type of blood clot called deep vein thrombosis(DVT), which can lead to blood clots in the lungs (pulmonary embolism).
Eliquis is also used to treat DVT or pulmonary embolism (PE), and to lower your risk of having a repeat DVTor PE.

Disclaimer

Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.